Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape. Pharmaceutical companies and their outsourcing partners must continuously adapt to ...

In today’s fast-paced world, threats can evolve quickly and without warning. As the pharmaceutical industry has operations and supply chains spanning the globe, companies are vulnerable to instability ...

In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula botulism outbreak, and more. To get it in your inbox, subscribe here. Merck ...

A federal judge officially approved drugmaker Purdue Pharma's $7.4 billion deal to settle thousands of lawsuits over the toll of the opioid epidemic and pay victims, prosecutors in the case told USA ...

AFTER AMERICA, China is the world’s largest developer of new medicines. Its companies ran nearly a third of the planet’s clinical trials last year. That is up from just 5% a decade before (see chart 1 ...

The new AI Document Creation tool generates professional contracts, policies, proposals and reports from simple prompts in seconds—no templates or blank-page starts requiredBOSTON, Dec. 10, 2025 ...

Ruth Gibson left her job in HR at a global pharmaceutical company six years ago. After 30 years at the firm and a decade of mulling over a career change, she is now a practising therapist. It took ...

The global pharmaceutical market is valued at $1.7 trillion, offering lucrative investment prospects. Choosing the right pharmaceutical stocks involves evaluating consistent revenue growth and robust ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Sweden's Sobi to buy US biotech Arthrosi for up to $1.5 billion to boost gout pipeline Drugmaker Swedish Orphan Biovitrum said on Saturday it had agreed to acquire U.S.-based biotechnology company ...

While moderating a panel between Van Jones and Robby Starbuck, SHRM President Johnny C. Taylor Jr. asked HR pros to embrace “real diversity, not just the diversity we’re comfortable with.” ...